It is unclear whether the density of these antigen-IgE-FcεRI clusters bears any linear relation to the use of sub-therapeutic dose or doses employed during DS, or whether non-linear synergetic effects can be obtained by the cross-linking events. The gene discussed is IGHE; the disease is Dravet syndrome.